SI0726324T1 - Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction - Google Patents
Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reactionInfo
- Publication number
- SI0726324T1 SI0726324T1 SI9630271T SI9630271T SI0726324T1 SI 0726324 T1 SI0726324 T1 SI 0726324T1 SI 9630271 T SI9630271 T SI 9630271T SI 9630271 T SI9630271 T SI 9630271T SI 0726324 T1 SI0726324 T1 SI 0726324T1
- Authority
- SI
- Slovenia
- Prior art keywords
- polymerase
- glycosylase
- exonuclease
- supplements
- chain reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
- C12Q2521/319—Exonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/50—Other enzymatic activities
- C12Q2521/531—Glycosylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38501995A | 1995-02-07 | 1995-02-07 | |
| EP96300791A EP0726324B1 (en) | 1995-02-07 | 1996-02-06 | Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0726324T1 true SI0726324T1 (en) | 2001-12-31 |
Family
ID=23519709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9630271T SI0726324T1 (en) | 1995-02-07 | 1996-02-06 | Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5985619A (xx) |
| EP (1) | EP0726324B1 (xx) |
| JP (1) | JPH08266298A (xx) |
| KR (1) | KR960031627A (xx) |
| AT (1) | ATE201452T1 (xx) |
| AU (1) | AU709788B2 (xx) |
| CA (1) | CA2168712A1 (xx) |
| DE (1) | DE69612885T2 (xx) |
| DK (1) | DK0726324T3 (xx) |
| ES (1) | ES2156978T3 (xx) |
| FI (1) | FI960540A (xx) |
| GR (1) | GR3036391T3 (xx) |
| NO (1) | NO960484L (xx) |
| PT (1) | PT726324E (xx) |
| SI (1) | SI0726324T1 (xx) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998054571A1 (en) * | 1997-05-28 | 1998-12-03 | The Walter And Eliza Hall Institute Of Medical Research | Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage |
| US6300075B1 (en) * | 1999-02-03 | 2001-10-09 | Ortho-Clinical Diagnostics, Inc | Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid |
| US7074556B2 (en) * | 1999-03-02 | 2006-07-11 | Invitrogen Corporation | cDNA synthesis improvements |
| FR2803601A1 (fr) * | 2000-01-11 | 2001-07-13 | Inst Nat Sante Rech Med | Utilisation de l'exonuclease iii dans des reactions d'amplification par polymerase de fragments d'adn |
| EP1275735A1 (en) | 2001-07-11 | 2003-01-15 | Roche Diagnostics GmbH | Composition and method for hot start nucleic acid amplification |
| US20040152072A1 (en) * | 2002-07-30 | 2004-08-05 | Invitrogen Corporation | Reverse transcription |
| ATE401423T1 (de) | 2003-05-01 | 2008-08-15 | Veridex Llc | Intraoperativer lymphknotentest |
| BRPI0510645A (pt) * | 2004-06-04 | 2007-11-20 | Veridex Llc | diagnóstico ou prognóstico do progresso do cáncer de mama, composição compreendendo conjuntos de iniciador/sonda de ácido nucléico e kit para análise de linfonodo intraoperativo |
| US20070154889A1 (en) * | 2004-06-25 | 2007-07-05 | Veridex, Llc | Methods and reagents for the detection of melanoma |
| JP5022383B2 (ja) * | 2006-02-27 | 2012-09-12 | エフ．ホフマン−ラ ロシュ アーゲー | マグネシウム封鎖によるｐｃｒホットスタート |
| BRPI0709282B8 (pt) | 2006-03-29 | 2021-05-25 | Merial Ltd | vacina contra estreptococos |
| CA2658520C (en) | 2008-03-19 | 2016-11-08 | F. Hoffmann-La Roche Ag | Nucleic acid amplification in the presence of modified randomers |
| US8258111B2 (en) | 2008-05-08 | 2012-09-04 | The Johns Hopkins University | Compositions and methods related to miRNA modulation of neovascularization or angiogenesis |
| US7910720B2 (en) * | 2008-09-09 | 2011-03-22 | Roche Diagnostics Operations, Inc. | Polyanion for improved nucleic acid amplification |
| CA2762986C (en) | 2009-05-22 | 2018-03-06 | Asuragen, Inc. | Mirna biomarkers of prostate disease |
| IL206810A (en) | 2009-07-08 | 2015-07-30 | Janssen Diagnostics Llc | Methods for identifying melanoma and kits for using these methods |
| EP2470897A4 (en) | 2009-08-28 | 2013-05-29 | Asuragen Inc | MICRO-RNA BIOMARKERS OF PULMONARY DISEASE |
| EP2772550B1 (en) | 2010-11-17 | 2017-03-29 | Interpace Diagnostics, LLC | Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms |
| US9758835B2 (en) | 2013-03-15 | 2017-09-12 | Baylor Research Institute | Ulcerative colitis (UC)-associated colorectal neoplasia markers |
| CA2907377A1 (en) | 2013-03-15 | 2014-09-18 | Baylor Research Institute | Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
| WO2015101653A1 (en) | 2014-01-05 | 2015-07-09 | Biomirna Holdings Ltd | Lung cancer determinations using mirna ratios |
| WO2015120382A1 (en) | 2014-02-07 | 2015-08-13 | The Johns Hopkins University | Predicting response to epigenetic drug therapy |
| GB201414745D0 (en) | 2014-08-19 | 2014-10-01 | Articzymes As | Exonucleases |
| WO2016094330A2 (en) | 2014-12-08 | 2016-06-16 | 20/20 Genesystems, Inc | Methods and machine learning systems for predicting the liklihood or risk of having cancer |
| WO2016177774A1 (en) | 2015-05-04 | 2016-11-10 | Academisch Medisch Centrum | Method of quantifying mirnas using normalization |
| US10081829B1 (en) | 2017-06-13 | 2018-09-25 | Genetics Research, Llc | Detection of targeted sequence regions |
| JP2019198259A (ja) * | 2018-05-15 | 2019-11-21 | 株式会社島津製作所 | １ステップｒｔ−ｐｃｒ法 |
| WO2020172362A1 (en) * | 2019-02-20 | 2020-08-27 | Genetics Research, Llc | Regulated multiplex reactions in a single tube |
| EP3719144A1 (en) | 2019-04-05 | 2020-10-07 | Fundación para la Investigación Biomédica del Hospital Universitario de la Paz (FIBHULP) | Mir-151a-3p as an universal endogenous control for exosome cargo normalization |
| US20220267857A1 (en) | 2019-07-19 | 2022-08-25 | Fundación Para La Investigación Biomédikca Del Hospital Universitario La Paz (Fibhulp) | Method for determining the response to treatment of a patient affected by non-small cell lung carcinoma (nsclc) |
| WO2021120095A1 (zh) * | 2019-12-19 | 2021-06-24 | 深圳华大生命科学研究院 | 抗聚合酶的单克隆抗体及其应用 |
| WO2023146243A1 (ko) * | 2022-01-26 | 2023-08-03 | 주식회사 씨젠 | 샘플 내 타겟 핵산을 검출하는 방법 |
| CN116773291B (zh) * | 2023-03-31 | 2024-04-19 | 艾普拜生物科技(苏州)有限公司 | 一种石蜡切片dna预处理试剂及方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69130800T2 (de) * | 1990-07-24 | 1999-09-16 | Hoffmann La Roche | Verringerung von nicht spezifischer amplifikation während einer (in vitro) nukleinsäure amplifikation unter verwendung von modifizierten nukleinsäure basen |
| EP0487218B1 (en) * | 1990-10-31 | 1997-12-29 | Tosoh Corporation | Method for detecting or quantifying target nucleic acid |
| CA2101119A1 (en) * | 1992-08-17 | 1994-02-18 | George T. Walker | Exonuclease decontamination method |
| US5338671A (en) * | 1992-10-07 | 1994-08-16 | Eastman Kodak Company | DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody |
| US5605796A (en) * | 1994-07-19 | 1997-02-25 | Behringwerke Ag | Method for preventing amplification of nucleic acid contaminants in amplification mixtures using nuclease-receptor conjugates |
-
1996
- 1996-02-02 CA CA002168712A patent/CA2168712A1/en not_active Abandoned
- 1996-02-06 FI FI960540A patent/FI960540A/fi unknown
- 1996-02-06 DE DE69612885T patent/DE69612885T2/de not_active Expired - Fee Related
- 1996-02-06 EP EP96300791A patent/EP0726324B1/en not_active Expired - Lifetime
- 1996-02-06 PT PT96300791T patent/PT726324E/pt unknown
- 1996-02-06 ES ES96300791T patent/ES2156978T3/es not_active Expired - Lifetime
- 1996-02-06 JP JP8020082A patent/JPH08266298A/ja active Pending
- 1996-02-06 NO NO960484A patent/NO960484L/no not_active Application Discontinuation
- 1996-02-06 AT AT96300791T patent/ATE201452T1/de not_active IP Right Cessation
- 1996-02-06 DK DK96300791T patent/DK0726324T3/da active
- 1996-02-06 SI SI9630271T patent/SI0726324T1/xx unknown
- 1996-02-06 AU AU43391/96A patent/AU709788B2/en not_active Ceased
- 1996-02-07 KR KR1019960002891A patent/KR960031627A/ko not_active Application Discontinuation
- 1996-05-08 US US08/643,282 patent/US5985619A/en not_active Expired - Lifetime
-
2001
- 2001-08-14 GR GR20010401247T patent/GR3036391T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0726324B1 (en) | 2001-05-23 |
| DE69612885T2 (de) | 2001-09-13 |
| US5985619A (en) | 1999-11-16 |
| KR960031627A (ko) | 1996-09-17 |
| ATE201452T1 (de) | 2001-06-15 |
| FI960540A0 (fi) | 1996-02-06 |
| DE69612885D1 (de) | 2001-06-28 |
| AU4339196A (en) | 1996-08-15 |
| NO960484D0 (no) | 1996-02-06 |
| EP0726324A2 (en) | 1996-08-14 |
| DK0726324T3 (da) | 2001-07-30 |
| FI960540A (fi) | 1996-08-08 |
| AU709788B2 (en) | 1999-09-09 |
| NO960484L (no) | 1996-08-08 |
| PT726324E (pt) | 2001-08-30 |
| JPH08266298A (ja) | 1996-10-15 |
| ES2156978T3 (es) | 2001-08-01 |
| CA2168712A1 (en) | 1996-08-08 |
| EP0726324A3 (en) | 1996-11-27 |
| GR3036391T3 (en) | 2001-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI0726324T1 (en) | Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction | |
| NO962062L (no) | Fremgangsmåte for polymerasekjede-reaksjons preamplifikasjons sterilisering ved eksonukleaser i nærvær av fosforotioaterte primere | |
| DE69308162D1 (de) | Methode zur amplification von ziel-gerichteten segmenten von nukleinsäure durch die ineinandergeschachtelte polymerase-kettenreaktion | |
| PT669401E (pt) | Amplificacao de sequencias compridas de acidos nucleicos | |
| DK0587266T3 (da) | Fremgangsmåde, sammensætning og kit til nukleinsyreamplifikation | |
| DE69523360T2 (de) | Isotherme Amplifikation von Nukleinsäuren durch Strangverdrängung | |
| EP2272952B8 (en) | Thermostable or thermoactive DNA polymerase with attenuated 3'-5' exonuclease activity | |
| Basu et al. | Synthesis of compositionally unique DNA by terminal deoxynucleotidyl transferase | |
| DE69532984D1 (de) | Verfahren zur Koamplifikation einer Zielnukleinsäure unter Versendung eines Volumenabscheidungsmittel in der Reaktionszusammensetzung, Testsatz und Testvorrichtung | |
| EP0632134A3 (en) | Reagent and method for high temperature reverse transcription followed by the polymerase chain reaction. | |
| EP1026261A3 (en) | Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid | |
| EP0751226A3 (en) | Process for amplifying nucleic acid sequences | |
| HK58397A (en) | Methods for purification amplification and detection of a nucleic acid |